Pharmaceuticals

Strong CAGR to Propel in the Cell Therapy Market and Beyond upto $29.28 Billion by 2029

May 27, 2025 by The Business Research Company

Discover trends, market shifts, and competitive outlooks for the cell therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Fast Is The Cell Therapy Market Expected to Grow Between 2025 And 2029?#_x000D_

The market size of cell therapy has seen a rapid expansion over the past few years. The market, which is expected to rise from $14.56 billion in 2024 to $17.02 billion in 2025, will have a compound annual growth rate (CAGR) of 16.9%. This growth during the historical period can be credited to initial research and breakthroughs, regulatory achievements, clinical tests and studies, early adopters, and trailblazing firms, as well as market approval and perception._x000D_

_x000D_

The market size of cell therapy is projected to experience a swift expansion in the coming years, growing to a worth of $29.28 billion in 2029, with a compound annual growth rate (CAGR) of 14.5%. The growth during the forecasted period is attributed to factors such as ethical and societal factors, investment trends and funding, consumer or patient demand, development in healthcare infrastructure, and the speed of innovation cycles. Noteworthy trends during these years include the rise in personalized medication, advancing targeted treatments, expansion in gene editing technologies, the growth of stem cell research, developing immunotherapy, and the manipulation of the microenvironment._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp_x000D_

_x000D_

#Which Primay Drivers Are Accelerating Growth in the Cell Therapy Market?#_x000D_

The escalation in the occurrence of chronic health conditions has played a pivotal role in the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) describes chronic diseases as ailments that persist for over one year or require ongoing medical treatment, hampering daily functions, or even both. This could include diseases like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells have proven to be beneficial for patients suffering from ailments such as spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency in the US, released significant updates concerning public health initiatives. Each year, heart disease or stroke claims the lives of over 944,800 Americans, amounting to more than a third of total deaths. Meanwhile, cancer, the second leading cause of death, is diagnosed in 1.7 million individuals in the U.S. annually, and causes over 600,000 deaths. Furthermore, over 38 million Americans are living with diabetes, and nearly 98 million adults are prediabetic, which raises their risk of developing type 2 diabetes. Diabetes can result in severe complications such as heart disease, kidney failure, and blindness. Moreover, obesity, affecting 20% of children and 42% of adults, further increases the risk of chronic diseases including type 2 diabetes, heart disease, and specific types of cancer. The escalating incidence of chronic diseases has boosted the demand for cell therapies, and in turn, has bolstered the growth of the cell therapy market._x000D_

_x000D_

#Which Primary Segments of the Cell Therapy Market Are Driving Growth and Industry Transformations?#_x000D_

The cell therapy market covered in this report is segmented –_x000D_

_x000D_

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy_x000D_

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies_x000D_

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy_x000D_

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine_x000D_

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy_x000D_

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy_x000D_

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Cell Therapy Market?# Market?#_x000D_

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Technological Trends Are Reshaping the Cell Therapy Industry Dynamics?#_x000D_

Major market participants are tactically forming partnerships and alliances to diversify their product offerings and extend their reach globally. For instance, in November 2023, Ajinomoto Co Inc., a renowned food corporation from Japan, took over Forge Biologics at a deal worth $620 million. The objective of this acquisition is to boost Ajinomoto Co Inc.’s worldwide effectiveness in AAV and plasmid gene therapy production, thereby enhancing and fortifying its pre-existing contract development and manufacturing services. Forge Biologics is an American biotech firm committed to the progression of cell therapy technologies aimed at treating a variety of diseases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Cell Therapy Market?#_x000D_

Cell therapy refers to the replacement or repair of damaged tissue and/or cells through the transplantation of human cells. Numerous different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders with the help of new technologies, inventive products, and infinite imagination. It is a form of treatment wherein a patient receives live cells via injection, grafting, or implant in order to produce a therapeutic result._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_